Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases.
Ann Rheum Dis
; 81(5): 720-728, 2022 05.
Article
en En
| MEDLINE
| ID: mdl-35022159
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
COVID-19
/
Vacuna BNT162
Tipo de estudio:
Observational_studies
Límite:
Humans
Idioma:
En
Año:
2022
Tipo del documento:
Article